| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2848952 | American Heart Journal | 2009 | 8 Pages |
Abstract
We found suboptimal patterns of adherence to thienopyridine therapy after DES implantation that was strongly associated with an increased mortality risk. Eliminating any costs for thienopyridine therapy may be an effective strategy to increase medication adherence.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dennis T. MD, MSc, Maria MSc, Helen MSc, Peter C. PhD, Jean-François MD, Jack V. MD, PhD,